Dr. Bluma Lesch is an Associate Professor at Yale School of Medicine with joint appointments in Genetics and Obstetrics, Gynecology & Reproductive Sciences. She directs a research program investigating epigenetic regulation in germline development and evolutionary biology, integrating molecular, computational, and developmental approaches. Her research focuses on: Epigenetic bivalency in germ cells Transgenerational inheritance mechanisms Chromatin dynamics in meiosis Evolution of gene regulatory networks Recent publications (2024-2025) demonstrate strong emphasis on: Histone modification mechanics Germline-specific chromatin remodeling Evolutionary transcriptomics Translational studies in fertility and disease models Honors include: Pew Biomedical Scholar (2021) Searle Scholar (2019) Burroughs Wellcome Career Award (2015) NIH Kirschstein Fellowship Hope Funds for Cancer Research Fellowship She leads the Lesch Lab , which employs genomic technologies and computational modeling to study epigenetic inheritance across biological scales.
Binyam Mogessie is an Assistant Professor in the Departments of Molecular, Cellular and Developmental Biology and Obstetrics, Gynecology, and Reproductive Sciences at Yale University. He is affiliated with the Yale Cancer Center, Yale Stem Cell Center, and serves on the Yale WRHR Advisory Committee. His research program focuses on the cytoskeletal and chromosomal mechanisms that ensure accurate chromosome segregation during oocyte meiosis and early embryogenesis, with particular emphasis on their links to reproductive aging. Dr. Mogessie earned his undergraduate degree in Biochemistry and Cell Biology from Jacobs University Bremen in Germany, followed by a PhD in Cell Biology from the University of London. His doctoral research was conducted at the Marie Curie Research Institute in Surrey and the Centre for Mechanochemical Cell Biology in Warwick, where he studied microtubule cytoskeleton organization. He completed postdoctoral training at the MRC Laboratory of Molecular Biology in Cambridge and the Max Planck Institute in Göttingen, where he made his groundbreaking discovery of actin's role in chromosome segregation during female meiosis. His lab investigates how the actin and microtubule cytoskeletons interact in space and time to drive accurate chromosome segregation and cellular organization. Based on discoveries of new cellular structures impacted by maternal aging, the lab is investigating how cytoskeletal dysfunction at advanced reproductive ages predisposes eggs and embryos to chromosomal abnormalities. The research employs advanced microscopy assays and targeted protein degradation tools to interrogate cell division mechanisms in mammalian oocytes and embryos. Dr. Mogessie's publication record shows consistent high-impact contributions to reproductive biology, with a focus shifting toward understanding the molecular mechanisms of reproductive aging in recent years. His work bridges fundamental cell biology with clinical implications for human fertility, particularly the age-related decline in egg quality. SSR Rising Star 2025 from Society for the Study of Reproduction Pew Scholar from The Pew Charitable Trusts (2024) Vallee Scholar from The Vallee Foundation (2024) Emerging Investigator Award from Society for Reproduction and Fertility (2023) Young Investigator from Human Frontier Science Program (2021) Cell Scientist to Watch from Journal of Cell Science (2021) Sir Henry Dale Fellow from Wellcome Trust and Royal Society (2019) Dr. Mogessie actively mentors students through Yale's Biological and Biomedical Sciences program and the Stem Cell Center. His lab has received substantial funding through prestigious awards including the Pew Scholarship and Vallee Scholarship, supporting research into the fundamental mechanisms of female meiosis and early embryogenesis. He serves on editorial boards for several leading cell biology journals and is engaged with professional societies including the American Society for Cell Biology. The Mogessie Lab applies innovative approaches to study cytoskeletal organization in mammalian eggs and embryos, with the mission to 'illuminate the molecular origins of human infertility and female reproductive aging.' The lab continues to make significant contributions to understanding how cytoskeletal dysfunction contributes to age-related declines in reproductive capacity.
Dr. Farzana Pashankar is a Professor of Pediatrics (Hematology/Oncology) at Yale School of Medicine with multiple leadership roles including Chair of the Faculty Mentoring Program, Fellowship Director of the Pediatric Hematology & Oncology Program, Director of the Solid Tumor Program, and Children's Oncology Group Site PI. She serves as Disease Aligned Research Team Leader for Pediatrics at Smilow Cancer Center and directs the Pediatric Hematology Oncology Fellowship Program. Dr. Pashankar received her MBBS and MD from University of Pune, India, trained in the United Kingdom earning an MRCP, completed residency at the University of Iowa, and fellowship at British Columbia Children's Hospital before joining Yale in 2005. Her research focuses on three main areas: sickle cell disease, rare tumors, and germ cell tumors. In sickle cell disease, she pioneered studies on pulmonary hypertension in children, demonstrated that hydroxyurea can reverse elevated pulmonary artery pressures, and developed quality improvement projects to reduce emergency department visits and hospitalizations. For rare tumors, she chaired the Infrequent Tumor Subcommittee at COG until 2020, developing guidelines for several rare tumors and completing international clinical trials for adrenocortical carcinoma and nasopharyngeal carcinoma. In germ cell tumors, her research has redefined management of immature teratomas, showing that grade is the most important risk factor for relapse and successfully advocating for observation alone in many cases that previously received chemotherapy. Her publication record shows strong activity in pediatric hematology-oncology with recent work spanning clinical trials, genomic studies of sickle cell complications, treatment guidelines for germ cell tumors, and quality improvement initiatives. Her research bridges clinical care, translational science, and health services research. 2016-2020: Faculty Honor Roll, Yale Pediatric Residency Program 2018: Semifinalist, Pediatric Quality Award, Children's Hospital Association 2015: Howard A. Pearson Pediatric Faculty Teaching Award 2012: Pediatric Residency Program Director's Award 2009: Pediatric Faculty Scholar Award, Yale University School of Medicine Dr. Pashankar actively mentors trainees through multiple roles including Fellowship Director and Chair of the Faculty Mentoring Program. She serves as Principal Investigator for several clinical trials and as Sub Investigator on additional trials. Her work with the Children's Oncology Group spans over 15 years, where she has chaired international trials in germ cell tumors. She collaborates extensively with colleagues at Yale, through the New York Connecticut Consortium, and the New England Pediatric Sickle Cell consortium. Dr. Pashankar's clinical work centers on providing comprehensive care for children with blood disorders and cancer, with particular expertise in sickle cell disease and solid tumors. She emphasizes building long-lasting relationships with families and states that watching advancements in the field that improve cure rates (now 80-85% for childhood cancer) has been a rewarding journey of her career.
Zachary Smith is an Assistant Professor (Adjunct) in the Department of Genetics at Yale School of Medicine, with additional affiliations at the Yale Stem Cell Center, Center for RNA Science and Medicine, and the Genomics, Genetics, and Epigenetics program. His research focuses on epigenetic regulation during mammalian development. Dr. Smith received his B.S. in Biology from M.I.T. in 2008 and his Ph.D. in Biology from Harvard University in 2019. His doctoral work focused on applying cutting-edge genomic technologies to understand chromatin dynamics during mammalian development. He joined the Yale Stem Cell Center and Department of Genetics as an Assistant Professor in September 2020. Dr. Smith's research program investigates three critical developmental processes: fertilization, implantation, and gastrulation. His lab seeks to understand how the genome is reconstructed after fertilization, how distinct epigenetic states are established in embryonic versus extraembryonic lineages, and how chromatin regulators orchestrate the complex process of gastrulation. They employ advanced genomic techniques including single-cell sequencing, Cas9-mediated genome editing, and novel molecular recording technologies. His recent publications highlight significant contributions to understanding DNA methylation dynamics in development and disease, X-chromosome biology, and the development of innovative genomic technologies. Dr. Smith's work bridges fundamental developmental biology with potential applications to understanding developmental disorders and cancer. Epigenetic regulation of mammalian development Chromatin dynamics during embryogenesis DNA methylation reprogramming Single-cell genomic analysis Novel molecular recording technologies Dr. Smith's lab collaborates extensively with researchers at Yale and other institutions, including Michael Caplan, Berna Sozen, and Biff Forbush. His interdisciplinary approach combines expertise in genetics, developmental biology, and technology development to address fundamental questions about how epigenetic mechanisms shape development. Students and postdocs in Dr. Smith's lab have opportunities to work at the forefront of developmental epigenetics, gaining expertise in both experimental and computational approaches to studying genome regulation during development.
Patrick Ferree serves as Professor of Biology in the Department of Natural Sciences at Claremont McKenna College, where he leads research on selfish genetic elements and their disruptive effects on reproductive processes in insect model systems. His work primarily utilizes the jewel wasp ( Nasonia vitripennis ) and fruit fly ( Drosophila melanogaster ) to investigate transmission mechanisms of B chromosomes and bacterial symbionts. His research portfolio spans several interconnected domains: Mechanisms of selfish genetic element transmission enhancement Host-parasite genetic conflicts in reproductive systems Haplo-diploid developmental biology Chromosome segregation and genome elimination systems Molecular basis of reproductive manipulations Comparative analysis of bacterial versus chromosomal symbionts Analysis of his 2020-2023 publications reveals a consistent methodological evolution toward integrated molecular approaches, with increasing use of CRISPR and genomic techniques to dissect selfish element mechanisms. His work demonstrates particular expertise in Nasonia chromosome biology, with multiple studies uncovering novel evasion strategies employed by B chromosomes against host genome defense systems. Professor Ferree teaches across the biology curriculum including Introductory Biology, Genetics, Developmental Biology, and Advanced Genetics courses. His lab provides undergraduate researchers with comprehensive training in both classical and cutting-edge genetic techniques within an active research program that regularly publishes in high-impact journals such as Science Advances and Current Biology.
Dr. Adriana Firooznia serves as a Lecturer in the Department of Chemistry and Physics at The Dorothy and George Hennings College of Science, Mathematics and Technology, Kean University. Her teaching portfolio spans foundational to advanced coursework including Biochemistry, Organic Chemistry, and General Chemistry lecture-laboratory sequences. Her academic credentials: Ph.D. in Biochemistry M.S. in Chemistry Dr. Firooznia's research expertise centers on protein biochemistry with dual emphases: structural enzymology (particularly glucoamylases) and molecular mechanisms of cellular processes (meiosis, spermiogenesis). Her work integrates protein engineering, structural analysis, and functional studies to explore chromosome dynamics, RNA regulation, and enzyme-substrate interactions. This interdisciplinary approach bridges fundamental biochemical principles with applications in reproductive biology and industrial biotechnology. Publication analysis (1996-2009) reveals an evolutionary trajectory from recombinant protein production and structural characterization toward complex biological systems. Early work established methodologies for enzyme expression and structural analysis, while later studies investigated protein functions in meiosis and spermatogenesis. This progression demonstrates increasing biological complexity in her research focus, consistently leveraging international collaborations across European institutions. Scientific recognition: No major awards or fellowships documented Her teaching-centered role emphasizes laboratory-based learning across eight undergraduate courses. While no dedicated research lab exists, course-integrated laboratories provide hands-on biochemistry training. She mentors students through laboratory instruction and potential independent studies, prioritizing development of analytical skills applicable to health, environmental, and medical challenges as articulated in her teaching philosophy. Research infrastructure utilizes departmental teaching laboratories rather than a dedicated research facility. Collaborative networks established through past publications may facilitate specialized student projects, though current research activity appears secondary to pedagogical responsibilities.
Dr. Lukas Stelzl is a Junior Group Leader at ReALity and IMB Associate Group Leader at the Institute of Molecular Biology (IMB), Johannes Gutenberg University Mainz. He serves as Principal Investigator at the Mainz Institute of Multiscale Modeling (M3ODEL) and Junior Faculty Member at Max Planck Graduate Center. His research employs multi-scale simulations to study biomolecular phase separation mechanisms. Research Focus: The Stelzl Lab investigates how liquid-liquid phase separation regulates cellular processes including: Transcriptional control in health vs. age-related diseases Post-transcriptional regulation during germ cell development Molecular specificity in disordered protein interactions Methodologically, the group develops simulation techniques bridging atomic-scale dynamics and mesoscale condensate formation. Key Collaborations: SFB/TRR 146: Multiscale soft matter simulations ReALity: Resilience and longevity research Max Planck Graduate Center training initiatives Lab website: Stelzl Lab
Muhammad Idrees is an Academic Clinical Instructor in the Division of Hematology and Oncology at the University of Washington School of Medicine. He serves as a Hospitalist at the University of Washington Medical Center - Montlake, with clinical expertise spanning Hospital Care, General Medical Oncology, and Hospice and Palliative Medicine. M.D. from Dow University of Medical Sciences Completed residency at Columbia University Bassett Medical Center Finished fellowship in Hospice and Palliative Care at New York University Medical Center - Long Island Campus Board certified by the American Board of Internal Medicine Dr. Idrees' research spans multiple disciplines including Hematology, Oncology, Hospital Medicine, Palliative Care, and Infectious Diseases. His work demonstrates significant contributions to understanding germ cell tumors, viral vector systems, biofilm-related infections, and cytokine storm syndromes. His research bridges clinical practice with scientific investigation, particularly in areas relevant to cancer treatment and patient care. Analysis of his publication record reveals a strong focus on translational medicine, with particular emphasis on testicular tumors, molecular pathology, and innovative therapeutic approaches. His work spans both basic science investigations and clinical applications, demonstrating versatility across the research spectrum. Active contributor to medical literature with publications from 2016-2025 Collaborates with researchers across multiple institutions globally Focus on both review articles and original research Dr. Idrees maintains an active clinical practice while contributing significantly to academic medicine through research and teaching. His dual role as clinician and researcher exemplifies the physician-scientist model, bridging patient care with scientific advancement in multiple medical disciplines.
C.L. Mulder is a Professor of Public Mental Health and Social Psychiatry in the Department of Psychiatry at Erasmus MC in Rotterdam, Netherlands. The researcher leads the Applied Social and Forensic Psychiatry group, which focuses on epidemiology and intervention studies to advance community-based mental healthcare. Dr. Mulder's educational background includes a PhD in PsychoImmunology of HIV Infection (1994, Cum Laude) and psychiatric training at Parnassia Psychiatric Institute (1999). In 2007, Dr. Mulder was appointed Professor of Public Mental Health at the Department of Psychiatry, Erasmus MC. Research interests focus on public mental health, social psychiatry, emergency psychiatry, prevention of coercion, assertive outreach, recovery, network psychiatry, and medication adherence. Dr. Mulder's work examines epidemiology and prevention of coercion, emergency psychiatry, medication adherence, and determinants of clinical, social and personal recovery. The research portfolio demonstrates significant contributions across two primary domains: mental health services research and reproductive medicine/fertility preservation. Recent publications show increasing interdisciplinary work bridging psychiatry with reproductive medicine, particularly in fertility preservation for patients undergoing cancer treatments. President of European Assertive Outreach Foundation Chair 'Generieke Module Drang en Dwang' Supervisory Board of Mind Chair of Quality Committee NVvP Board member FACT Nederland Board member Stichting HIC Board member Stichting Resourcegroepen Advisory board CCAF Board member Phrenos Dr. Mulder supervises medical students, PhD students, and psychiatry residents. Research projects include studies on difficult-to-engage patients, the iBerry study on adolescent development, and the UP'S study assessing recovery determinants in psychotic disorder patients. Multiple research grants support this work across the various research domains. Dr. Mulder leads the Applied Social and Forensic Psychiatry research group, which employs epidemiology and intervention studies to advance community-based mental healthcare. The group collaborates with mental health institutions, the municipal health center of Rotterdam, and Erasmus MC as part of the Epidemiological and Social Psychiatric Research institute.
Dr. Philipp Denninger serves as a Group Leader at the Chair of Plant Systems Biology within the TUM School of Life Sciences at Technical University of Munich. Appointed in July 2019, he leads an independent research group focused on plant cell polarity mechanisms under the supervision of Prof. Dr. Claus Schwechheimer. His habilitation process in Plant Cell Biology began in March 2022, marking his progression toward a professorial qualification in the German academic system. Dr. Denninger's research centers on understanding cell polarity and signal transduction in plants, particularly investigating the RhoGTPases (ROP) and their activating guanine nucleotide exchange factors (ROPGEFs). His laboratory employs model systems including Arabidopsis thaliana , Marchantia polymorpha , and Zea mays to study pollen tube growth, cell division, and other polarization events. The group utilizes advanced techniques such as confocal microscopy, image analysis, and quantitative protein-protein interaction studies (MST, FRET) to unravel the spatiotemporal composition of ROP signaling complexes during polar growth. Analysis of Dr. Denninger's publication record reveals a consistent focus on ROP signaling mechanisms across multiple plant developmental contexts. His work demonstrates how specific ROPGEFs establish polar membrane domains that drive processes like pollen germination and root hair outgrowth. The research trajectory shows progression from identifying individual ROPGEF functions to understanding the dynamic repositioning of polarity domains and the negative regulation of polar growth pathways. 2019: Otto Schmeil Award from the Schmeil Foundation Heidelberg for an excellent dissertation 2013: Master's Prize from the Biochemistry Center Regensburg 2012: DAAD scholarship for research at Carnegie Institution of Science, Stanford University Dr. Denninger's laboratory operates within the Chair of Plant Systems Biology, collaborating with international research groups across Europe and North America. His research program integrates in vivo imaging approaches with in vitro biochemical techniques to address fundamental questions about how plants establish and maintain cellular polarity during development. Current projects focus on determining how polarity domain positions are established and how uncontrolled polar growth is regulated to ensure normal plant development.
Mary Kinkel is an Associate Professor of Developmental Biology in the Department of Biology at Appalachian State University. Her research focuses on vertebrate developmental biology, particularly the patterning of the endodermal germ layer and pancreas development using zebrafish models. Education: PhD, School of Biomedical Sciences, Kent State University, OH MA, Biological Anthropology, Kent State University, OH BA, Anthropology, University of South Florida Dr. Kinkel's research centers on understanding how pancreas cell types are specified, how organ size is determined, and how the pancreas is correctly localized within the embryo. Her work particularly focuses on pancreatic beta cells, which synthesize and secrete insulin and play a critical role in blood sugar control. She employs zebrafish as a model organism, utilizing genetic tools including transgenic and mutant fish lines. Her research has significant implications for understanding diabetes, as beta cell failure is the ultimate cause of all types of diabetes. Analysis of her publication history reveals a clear research trajectory from anthropological studies in the early 1990s to specialized developmental biology with a focus on pancreatic development and beta cell formation. Her most recent work (2017-2019) continues to build on her expertise in zebrafish models for pancreatic disease and larval rearing methods, demonstrating sustained research activity in her field. Dr. Kinkel's laboratory investigates the molecular mechanisms of endoderm patterning, with particular emphasis on retinoic acid signaling, Cyp26 enzymes, and Cdx4 factors in determining pancreatic field size and localization. Her research integrates multiple signaling pathways including canonical Wnt signaling to refine models of endoderm development. Her professional experience includes positions as Associate Scientist/Assistant Professor at Sanford Research Center/University of South Dakota and Research Associate (Assistant Professor) at The University of Chicago, following postdoctoral training at the same institution.
Jørgen Holm Petersen serves as an Associate Professor in the Department of Public Health within the Faculty of Health and Medical Sciences at the University of Copenhagen. His primary academic affiliation centers on the Section of Biostatistics, where he maintains an active research profile with over 240 research outputs and significant collaborative networks across international institutions. His research expertise spans specialized statistical methodologies including inter-rater agreement analysis, reference curve development, latent variable modeling, and variance components models. Current work focuses on Bradley-Terry models with variance components for estimation and inference, particularly in rater agreement contexts. His methodological innovations directly support clinical and epidemiological investigations across endocrinology, environmental health, and public health domains. Recent publication trends reveal strong engagement with endocrine development research (puberty studies, hormone assays), environmental carcinogenesis (PFAS/organochlorine exposures), and health disparities (long COVID, vaccination uptake). His statistical frameworks enable sophisticated analysis of complex human exposures and longitudinal health outcomes, frequently applied through collaborations with clinical researchers at Copenhagen University Hospital. Petersen actively contributes to academic discourse through lectures on biostatistical applications in diverse fields (astronomy, voice research, cosmology) and service on review committees. His methodological presentations address critical issues in clinical trial randomization, instrumental variable techniques, and rating scale modeling for observer variation. Professional activities include editorial roles, committee chairmanships (e.g., Assessment Committee since 2014), and extensive lecture contributions. His work bridges theoretical statistics with practical healthcare applications, particularly in developmental endocrinology and environmental epidemiology.
Hannah Rebecca Schorle is a Postdoctoral Research Fellow in the Department of Cellular and Molecular Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, specializing in the Molecular Aging Program. Her research focuses on female germ line mechanisms, particularly the causes of aneuploidy and pathways linked to ovarian ageing. Her primary research interests include germ cell development , meiotic recombination , DNA damage response and repair , oogenesis , and ovarian ageing . She investigates the connections between DNA damage response pathways, meiotic recombination errors, and germ cell development abnormalities using advanced cellular models. Her collaborative work spans cancer biology and cellular migration mechanisms, as evidenced by her 2021 publication in Cancers . This research explored PTEN loss effects on durotaxis and RhoB-dependent amoeboid migration in 3D scaffolds. No scientific awards or formal advisees are documented in the available records. Her laboratory work operates within the Hoffmann Group's research framework at the University of Copenhagen.
Jakub Sedzinski is an Associate Professor and Group Leader at the Department of Biomedical Sciences, University of Copenhagen, where he leads the Sedzinski Lab as part of reNEW (Novo Nordisk Foundation Center for Stem Cell Medicine). His research focuses on understanding cellular mechanisms in development and tissue regeneration, with particular emphasis on epithelial integration, multiciliated cell development, and the mechanical interplay between cells and their microenvironment. Dr. Sedzinski's research interests span developmental biology, cell biology, and biomechanics. His work investigates how cells integrate into tissues during development and regeneration, with a special focus on multiciliated cells and their role in epithelial function. He employs advanced techniques including in vivo imaging, single-cell profiling, and mechanical analysis to uncover fundamental principles of tissue organization and cell behavior. His research has significant implications for understanding developmental disorders and regenerative processes. Analysis of Dr. Sedzinski's recent publications reveals a strong focus on the mechanical aspects of cell integration and tissue morphogenesis. His work bridges developmental biology with biophysics, examining how physical forces influence cell fate decisions and tissue organization. A recurring theme is the investigation of multiciliated cells and their integration into epithelial tissues, with implications for understanding respiratory and other epithelial disorders. His research spans from molecular mechanisms to tissue-level organization, providing comprehensive insights into developmental processes. Dr. Sedzinski leads the Sedzinski Lab at reNEW, which includes postdocs, PhD fellows, and master's students working collaboratively on various aspects of cell and developmental biology. His team employs interdisciplinary approaches combining genetics, imaging, and biomechanical analysis to address fundamental questions in tissue development and regeneration. The lab's work is highly collaborative, with connections to other research groups within reNEW and internationally.
